Article in Nanomedicine (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Jia Sheng YewCentre for Virus & Vaccine Research, School of Medical & Life Sciences, Sunway University, Petaling Jaya, 47500, Malaysia.
Seng-Kai OngDepartment of Biological science, School of Medical & Life Sciences, Sunway University, Petaling Jaya, 47500, Malaysia.
Hui Xuan LimCentre for Virus & Vaccine Research, School of Medical & Life Sciences, Sunway University, Petaling Jaya, 47500, Malaysia.
Soon Hao TanDepartment of Biomedical Science, Faculty of Medicine, Universiti Malaya, Federal Territory of Kuala Lumpur, Kuala Lumpur, 50603, Malaysia.
Kien Chai OngDepartment of Biomedical Science, Faculty of Medicine, Universiti Malaya, Federal Territory of Kuala Lumpur, Kuala Lumpur, 50603, Malaysia.
Kum Thong WongDepartment of Pathology, Faculty of Medicine, Universiti Malaya, Federal Territory of Kuala Lumpur, Kuala Lumpur, 50603, Malaysia.
Chit Laa PohCentre for Virus & Vaccine Research, School of Medical & Life Sciences, Sunway University, Petaling Jaya, 47500, Malaysia.ORCID 0000-0001-8475-6291
Funding
Sunway University International Network Grant Scheme STR-IRNGS-SMLS-CVVR-01-2021
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
ChitosanEnterovirus A, HumanHand, Foot and Mouth DiseaseNanoparticlesVaccines, DNAAnimalsCapsid ProteinsFemaleHumansInterferon-gammaMiceMice, Inbred BALB CPlasmidsPolyphosphatesViral VaccinesCapsid ProteinsChitosanInterferon-gammaPolyphosphatestriphosphoric acidVaccines, DNAViral VaccinesDNAimmunology/infectious diseasesnanoparticlesvaccinesviruses
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Immunogenicity of trivalent DNA vaccine candidate encapsulated in Chitosan-TPP nanoparticles against EV-A71 and CV-A16. · full record | Socratic